Because iodine is a large halogen, approximately the size of a phenyl ring, the radiolabeling of small molecule PD-L1 inhibitors with radioiodine potentially alters the physicochemical and biological properties, which could have a negative impact on the binding affinities and tumor uptake [123]. Here, CD274 is linked to neoplasm.